ÂÜÀòÂÒÂ×

The Clinical and Commercial Development team at Aldeyra Therapeutics is responsible for advancing clinical trials, developing market access strategies, and translating scientific research into viable treatment options for aldehyde toxicity-related diseases such as Sjögren-Larsson Syndrome and noninfectious anterior uveitis. This team ensures that innovative therapies reach patients effectively by coordinating between clinical research, strategy development, and market implementation.